Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ESHAP regimen

Known as: Etoposide-Solumedrol-High Dose Ara-C, Platinol Regimen 
A regimen consisting of etoposide, methylprednisolone, high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and non… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Diffuse large B-cell lymphoma (DLBCL) patients failing rituximab-containing therapy have a poor outcome with the current salvage… Expand
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Is this relevant?
2010
2010
BACKGROUND High-dose chemotherapy (HDT) followed by autologous stem-cell transplantation (ASCT) is considered the gold standard… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
AIM To analyze toxicity, response and outcome of a phase II trial with intensive chemotherapy plus autologous stem-cell… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND The role of re-treatment with rituximab in aggressive B-cell lymphomas still needs to be defined. This study evaluated… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2008
2008
We describe the rare case of a 53-year-old woman with systemic involvement of Langerhans cell sarcoma (LCS) who had undergone… Expand
Is this relevant?
2007
2007
BACKGROUND We evaluated the efficacy and safety of adding rituximab to nonanthracycline ESHAP (etoposide/methylprednisolone… Expand
Is this relevant?
2006
2006
Successful mobilization and transplantation of filgrastim mobilized hematopoietic stem cells in sickle cell-hemoglobin C disease 
Is this relevant?
2002
2002
The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1999
1999
The purpose was study the feasibility of ESHAP + G-CSF for peripheral blood hematopoietic progenitor cell (PBPC) mobilisation in… Expand
Is this relevant?
1998
1998
High-dose therapy with peripheral blood stem cell (PBSC) support is a frequently used treatment option in younger patients with… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?